pI: 4.482 |
Length (AA): 108 |
MW (Da): 12385 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 86 | 3ner (A) | 0 | 85 | 56.00 | 0 | 1 | 1.5796 | -1.59 |
2 | 86 | 2ibj (A) | 1 | 85 | 56.00 | 0 | 1 | 1.59234 | -1.81 |
2 | 96 | 1hko (A) | 5 | 99 | 54.00 | 0 | 1 | 1.58693 | -1.03 |
4 | 80 | 1cxy (A) | 6 | 86 | 43.00 | 0.00000000085 | 1 | 1.37166 | -1.87 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126967)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G53560 | cytochrome B5 isoform E |
Arabidopsis thaliana | AT1G26340 | cytochrome B5 isoform A |
Arabidopsis thaliana | AT5G48810 | cytochrome B5 isoform D |
Arabidopsis thaliana | AT2G32720 | cytochrome B5 isoform B |
Brugia malayi | Bm1_32920 | Cytochrome b5-like Heme/Steroid binding domain containing protein |
Brugia malayi | Bm1_32100 | Cytochrome b5-like Heme/Steroid binding domain containing protein |
Candida albicans | CaO19.1397 | similar to cytochrome b5 but contains N and C terminal extensions |
Candida albicans | CaO19.7049 | similar to S. cerevisiae CYB5 (YNL111C) cytochrome b5 |
Candida albicans | CaJ7_0084 | hypothetical protein |
Candida albicans | CaO19.8975 | similar to cytochrome b5 but contains N and C terminal extensions |
Caenorhabditis elegans | CELE_D2023.1 | Protein D2023.1, isoform G |
Caenorhabditis elegans | CELE_C31E10.7 | Protein CYTB-5.1 |
Caenorhabditis elegans | CELE_W02D3.1 | Protein CYTB-5.2 |
Dictyostelium discoideum | DDB_G0276033 | cytochrome b5 A |
Dictyostelium discoideum | DDB_G0278753 | cytochrome b5 C |
Dictyostelium discoideum | DDB_G0277079 | cytochrome b5 B |
Drosophila melanogaster | Dmel_CG2140 | Cytochrome b5 |
Drosophila melanogaster | Dmel_CG3566 | CG3566 gene product from transcript CG3566-RB |
Echinococcus granulosus | EgrG_000701000 | cytochrome B5 |
Echinococcus multilocularis | EmuJ_000701000 | cytochrome B5 |
Homo sapiens | ENSG00000166347 | cytochrome b5 type A (microsomal) |
Homo sapiens | ENSG00000103018 | cytochrome b5 type B (outer mitochondrial membrane) |
Leishmania braziliensis | LbrM.11.0460 | cytochrome b5, putative |
Leishmania braziliensis | LbrM.09.1550 | cytochrome b5-like protein, putative |
Leishmania braziliensis | LbrM.02.0070 | cytochrome b-domain protein, putative |
Leishmania donovani | LdBPK_110490.1 | cytochrome b5, putative |
Leishmania donovani | LdBPK_020020.1 | cytochrome b-domain protein, putative |
Leishmania donovani | LdBPK_091570.1 | cytochrome b5-like, putative |
Leishmania donovani | LdBPK_091580.1 | cytochrome b5-like protein |
Leishmania infantum | LinJ.11.0490 | cytochrome b5, putative |
Leishmania infantum | LinJ.09.1570 | cytochrome b5-like protein, putative |
Leishmania infantum | LinJ.02.0020 | cytochrome b-domain protein, putative |
Leishmania infantum | LinJ.09.1580 | cytochrome b5-like protein |
Leishmania major | LmjF.11.0580 | cytochrome b5, putative |
Leishmania major | LmjF.02.0050 | cytochrome b-domain protein, putative |
Leishmania major | LmjF.09.1490 | cytochrome b5-like protein, putative |
Leishmania mexicana | LmxM.11.0580 | cytochrome b5, putative |
Leishmania mexicana | LmxM.09.1490 | cytochrome b5-like protein, putative |
Leishmania mexicana | LmxM.02.0050 | cytochrome b-domain protein, putative |
Loa Loa (eye worm) | LOAG_02355 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11399 | cytochrome b5 |
Mus musculus | 102641759 | cytochrome b5 type B-like |
Mus musculus | ENSMUSG00000031924 | cytochrome b5 type B |
Mus musculus | 109672 | cytochrome b5 type A (microsomal) |
Neospora caninum | NCLIV_007030 | Cytochrome b5, related |
Oryza sativa | 4330160 | Os02g0649800 |
Oryza sativa | 4349127 | Os10g0518200 |
Oryza sativa | 4337583 | Os05g0108800 |
Oryza sativa | 4351805 | Os12g0223300 |
Plasmodium berghei | PBANKA_1447000 | cytochrome b5, putative |
Plasmodium falciparum | PF3D7_1232300 | cytochrome b5, putative |
Plasmodium knowlesi | PKNH_1451800 | cytochrome b5, putative |
Plasmodium vivax | PVX_100560 | cytochrome b5, putative |
Plasmodium yoelii | PY04794 | hypothetical protein |
Saccharomyces cerevisiae | YNL111C | Cyb5p |
Schistosoma japonicum | Sjp_0026290 | Cytochrome b5 type B precursor, putative |
Schistosoma mansoni | Smp_066010.2 | cytochrome B5 |
Schistosoma mansoni | Smp_066010.1 | cytochrome B5 |
Schmidtea mediterranea | mk4.004065.02 | Putative cytochrome b5 |
Trypanosoma brucei gambiense | Tbg972.11.7510 | cytochrome b5, putative |
Trypanosoma brucei gambiense | Tbg972.11.15240 | cytochrome b5, putative |
Trypanosoma brucei | Tb927.11.13650 | cytochrome b5, putative |
Trypanosoma brucei | Tb927.11.6640 | cytochrome b5, putative |
Trypanosoma cruzi | TcCLB.509395.100 | cytochrome b-domain protein, putative |
Trypanosoma cruzi | TcCLB.503653.60 | cytochrome b-domain protein, putative |
Trypanosoma cruzi | TcCLB.510355.269 | cytochrome b5, putative |
Trypanosoma cruzi | TcCLB.506773.44 | cytochrome b5, putative |
Trypanosoma cruzi | TcCLB.508799.160 | cytochrome b5-like protein, putative |
Trypanosoma cruzi | TcCLB.506753.110 | cytochrome b5-like protein, putative |
Toxoplasma gondii | TGME49_276110 | cytochrome b5 family heme/steroid binding domain-containing protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5225 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5225 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5225 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5225 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.02.4485 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.4485 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.4485 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.4485 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C31E10.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C31E10.7 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C31E10.7 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C31E10.7 | Caenorhabditis elegans | slow growth | wormbase |
CELE_W02D3.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W02D3.1 | Caenorhabditis elegans | larval arrest | wormbase |
TGME49_276110 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.